Back
Michel Sadelain
Memorial Sloan Kettering Cancer Center
2024 Breakthrough Prize in Life Sciences
For the development of chimeric antigen receptor T cell immunotherapy whereby the patient’s T cells are modified to target and kill cancer cells.